More on BYSI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (4.4 Score)

Upcoming Events

- Earnings (9/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BeyondSpring (NQ:BYSI)
Delayed: 1.17 +0.05 (4.46%)
Prev. Close $1.12  
Open$1.11 
52 Wk High$ 
52 Wk Low$ 
Day High$1.19 
Day Low$1.11 
P/E N/A  
EPS$ 
Volume9,766 


Jul 6, 2026 01:11 PM Form 4 BeyondSpring Inc. For: Jul 01 Filed by: Majeti Jiangwen
Jul 6, 2026 01:11 PM Form 4 BeyondSpring Inc. For: Jul 01 Filed by: Qiu Min
Jul 6, 2026 01:10 PM Form 3 BeyondSpring Inc. For: Jul 01 Filed by: Qiu Min
Jul 6, 2026 01:09 PM Form 3 BeyondSpring Inc. For: Jul 01 Filed by: Li Na (NL)
Jun 29, 2026 04:31 PM Form 8-K/A BeyondSpring Inc. For: Jun 04
Jun 4, 2026 07:30 AM Form 8-K BeyondSpring Inc. For: Jun 04
Jun 4, 2026 07:01 AM BeyondSpring names new CEO as founder transitions to chairman role
Jun 4, 2026 07:00 AM BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
Jun 2, 2026 07:01 AM BeyondSpring reports phase 2 trial results for lung cancer treatment
Jun 2, 2026 07:00 AM BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune
View All Articles

Entities mentioned with BYSI

View All Entities